These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9455745

  • 1. Nonprogressive CMV retinitis in AIDS patients with protease inhibitors therapy for AIDS.
    Ortega-Larrocea G, Feregrino-Goyos M.
    Ocul Immunol Inflamm; 1997 Dec; 5(4):279-82. PubMed ID: 9455745
    [Abstract] [Full Text] [Related]

  • 2. Cytomegalovirus retinitis in advanced HIV-infected patients treated with protease inhibitors: incidence and outcome over 2 years.
    Labetoulle M, Goujard C, Frau E, Rogier H, Niessen F, Furlan V, Lantz O, Lecointe D, Delfraissy JF, Offret H.
    J Acquir Immune Defic Syndr; 1999 Nov 01; 22(3):228-34. PubMed ID: 10770342
    [Abstract] [Full Text] [Related]

  • 3. Protease inhibitors linked to drop in CMV retinitis.
    AIDS Alert; 1997 Aug 01; 12(8):92-4. PubMed ID: 11364475
    [Abstract] [Full Text] [Related]

  • 4. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
    Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR.
    J Infect Dis; 1998 May 01; 177(5):1182-7. PubMed ID: 9593001
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
    Walton RC, Whitcup SM, Mueller BU, Lewis LL, Pizzo PA, Nussenblatt RB.
    Ophthalmology; 1995 Dec 01; 102(12):1865-70. PubMed ID: 9098289
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
    Tural C, Romeu J, Sirera G, Andreu D, Conejero M, Ruiz S, Jou A, Bonjoch A, Ruiz L, Arnó A, Clotet B.
    J Infect Dis; 1998 Apr 01; 177(4):1080-3. PubMed ID: 9534987
    [Abstract] [Full Text] [Related]

  • 10. [Cytomegalovirus retinitis after highly active antiretroviral therapy: a case report].
    Andonegui Navarro J, Aldamiz-Etxebarría M.
    Arch Soc Esp Oftalmol; 2002 Sep 01; 77(9):515-7. PubMed ID: 12221545
    [Abstract] [Full Text] [Related]

  • 11. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS.
    Tanguilig GG, Rutzen AR, Ortega-Larrocea G.
    Am J Ophthalmol; 1998 Apr 01; 125(4):567-8. PubMed ID: 9559752
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Control of cytomegalovirus retinitis after combination antiretroviral therapy.
    Ruhswurm I, Ries E, Krepler K, Derbolav A, Rieger A, Armbruster C, Wedrich A.
    Acta Ophthalmol Scand; 1999 Aug 01; 77(4):471-3. PubMed ID: 10463426
    [Abstract] [Full Text] [Related]

  • 14. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1.
    Komanduri KV, Viswanathan MN, Wieder ED, Schmidt DK, Bredt BM, Jacobson MA, McCune JM.
    Nat Med; 1998 Aug 01; 4(8):953-6. PubMed ID: 9701250
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of potent antiretroviral therapy on recurrent cytomegalovirus retinitis treated with the ganciclovir implant.
    Davis JL, Tabandeh H, Feuer WJ, Kumbhat S, Roth DB, Chaudhry NA.
    Am J Ophthalmol; 1999 Mar 01; 127(3):283-7. PubMed ID: 10088737
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
    Vrabec TR, Baldassano VF, Whitcup SM.
    Ophthalmology; 1998 Jul 01; 105(7):1259-64. PubMed ID: 9663231
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.
    Ries E, Mühlbauer B, Ruhswurm I, Krepler K, Derbolav A, Svolba G, Rieger A, Wedrich A.
    Ophthalmologica; 1998 Jul 01; 212(4):239-43. PubMed ID: 9672212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.